Cisatracurium
- Generic Name
- Cisatracurium
- Brand Names
- Nimbex
- Drug Type
- Small Molecule
- Chemical Formula
- C53H72N2O12
- CAS Number
- 96946-41-7
- Unique Ingredient Identifier
- QX62KLI41N
- Background
Cisatracurium is a non-depolarising neuromuscular blocking agent of the benzylisoquinolinium class, available in its salt form, cisatracurium besylate. Cisatracurium has an intermediate duration of action and is one of the most commonly used neuromuscular blocking agents in intensive care.. Cisatracurium acts on cholinergic receptors, blocking neuromuscular ...
- Indication
Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilati...
- Associated Conditions
- -
- Associated Therapies
- General Anesthesia, Skeletal muscle relaxation for mechanical ventilation, Smooth muscle relaxation prior to radiological procedures therapy
Thoracic Paravertebral Block in Pain Management After Renal Surgery
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2016-07-21
- Lead Sponsor
- Silesian University of Medicine
- Target Recruit Count
- 58
- Registration Number
- NCT02840526
- Locations
- 🇵🇱
Samodzielny Publiczny Szpital Kliniczny nr 1 SUM Zabrze, Zabrze, Slaskie, Poland
Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 100
- Registration Number
- NCT02635542
- Locations
- 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
Gender and PK-PD of Propofol and Cisatracurium
- First Posted Date
- 2015-10-27
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Medical University of Graz
- Target Recruit Count
- 120
- Registration Number
- NCT02588118
- Locations
- 🇨🇳
Xijing hospital of Fourth Military Medical University, Xi'an, Shaanxi, China
🇦🇹Medical University of Graz, Graz, Austria
Depth of Neuromuscular Blockade and the Perioperative Conditions in Laparoscopic Surgery in Pediatric Population
- Conditions
- Interventions
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- Brno University Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT02546843
- Locations
- 🇨🇿
University Hospital Brno - FN Brno, Brno, Czech Republic, Czechia
The Efficacy and Optimal Dose of Sufentanil in Patient Controlled Analgesia After Moderate Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-07-21
- Last Posted Date
- 2015-07-21
- Target Recruit Count
- 60
- Registration Number
- NCT02503826
Effects of Cisatracurium on Sccinylcholine-induced Fasciculations
- First Posted Date
- 2015-07-17
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- Zhuan Zhang
- Target Recruit Count
- 87
- Registration Number
- NCT02502032
Effects of Intravenous Lidocaine Associated With Magnesium Sulfate on the Cisatracurium-Induced Neuromuscular Block
- Conditions
- Interventions
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2016-01-15
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 48
- Registration Number
- NCT02483611
Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- Yangzhou No.1 People's Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT02481193
Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)
- Conditions
- Interventions
- First Posted Date
- 2015-04-07
- Last Posted Date
- 2015-07-13
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Registration Number
- NCT02410590
Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis
- Conditions
- Interventions
- First Posted Date
- 2014-07-18
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT02194855
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.